A patient with pure red cell aplasia after allogenic stem-cell transplantation

Netherlands Journal of Medicine

Volumn 71, Issue 7, 2013, Pages

  Berrevoets, M A H ^a   van der Post, R S ^a   Schaap, N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COTRIMOXAZOLE; FERRITIN; HEMOGLOBIN; IMMUNOGLOBULIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CASE REPORT; DRUG WITHDRAWAL; ERYTHEMA INFECTIOSUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOTE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PURE RED CELL ANEMIA; RETICULOCYTE COUNT;

HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84884178278     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Young NS, Brown KE. Parvovirus B19. New Engl J Med. 2004;350:586-97.
2. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43:40-8.
3. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. New Engl J Med. 1989;321:519-23.
4. Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013;56:968-77.